{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:09Z","timestamp":1707525069691},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.7759\/cureus.39848","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T01:54:17Z","timestamp":1685670857000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Review of the Efficacy of Droperidol Compared to Prochlorperazine for Headache Management in the Emergency Department"],"prefix":"10.7759","author":[{"given":"Gabrielle K","family":"Driller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianne","family":"Remigio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hootman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies","volume":"58","author":"Burch R","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018, 58:496-505. 10.1111\/head.13281","journal-title":"Headache"},{"key":"ref2","unstructured":"National Hospital Ambulatory Medical Care Survey. 2017 emergency department summary tables. (2017). Accessed: 9\/23\/2022: https:\/\/www.cdc.gov\/nchs\/data\/nhamcs\/web_tables\/2017_ed_web_tables-508.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.06.023","article-title":"Managing migraine","volume":"69","author":"Friedman BW","year":"2017","unstructured":"Friedman BW. Managing migraine. Ann Emerg Med. 2017, 69:202-7. 10.1016\/j.annemergmed.2016.06.023","journal-title":"Ann Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/head.12550","article-title":"Acute migraine treatment in adults","volume":"55","author":"Becker WJ","year":"2015","unstructured":"Becker WJ. Acute migraine treatment in adults. Headache. 2015, 55:778-93. 10.1111\/head.12550","journal-title":"Headache"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura MJ","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015, 55:3-20. 10.1111\/head.12499","journal-title":"Headache"},{"key":"ref6","article-title":"Treatment of acute migraine headache","volume":"83","author":"Gilmore B","year":"2011","unstructured":"Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011, 83:271-80.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department","volume":"21","author":"Cole JB","year":"2020","unstructured":"Cole JB, Lee SC, Martel ML, Smith SW, Biros MH, Miner JR. The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department. West J Emerg Med. 2020, 21:728-36. 10.5811\/westjem.2020.4.47036","journal-title":"West J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000281893.39781.64","article-title":"Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?","volume":"107","author":"Nuttall GA","year":"2007","unstructured":"Nuttall GA, Eckerman KM, Jacob KA, et al.. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?. Anesthesiology. 2007, 107:531-6. 10.1097\/01.anes.0000281893.39781.64","journal-title":"Anesthesiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000042477.63516.b2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein SD","year":"2003","unstructured":"Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS. Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology. 2003, 60:315-21. 10.1212\/01.wnl.0000042477.63516.b2","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014554445","article-title":"Droperidol for the treatment of acute migraine headaches","volume":"49","author":"Thomas MC","year":"2015","unstructured":"Thomas MC, Musselman ME, Shewmaker J. Droperidol for the treatment of acute migraine headaches. Ann Pharmacother. 2015, 49:233-40. 10.1177\/1060028014554445","journal-title":"Ann Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2001.tb01147.x","article-title":"Droperidol vs. prochlorperazine for benign headaches in the emergency department","volume":"8","author":"Miner JR","year":"2001","unstructured":"Miner JR, Fish SJ, Smith SW, Biros MH. Droperidol vs. prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001, 8:873-9. 10.1111\/j.1553-2712.2001.tb01147.x","journal-title":"Acad Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(99)90096-7","article-title":"Droperidol for acute migraine headache","volume":"17","author":"Richman PB","year":"1999","unstructured":"Richman PB, Reischel U, Ostrow A, et al.. Droperidol for acute migraine headache. Am J Emerg Med. 1999, 17:398-400. 10.1016\/S0735-6757(99)90096-7","journal-title":"Am J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2003.05.005","article-title":"Droperidol vs prochlorperazine for the treatment of acute headache","volume":"26","author":"Weaver CS","year":"2004","unstructured":"Weaver CS, Jones JB, Chisholm CD, et al.. Droperidol vs prochlorperazine for the treatment of acute headache. J Emerg Med. 2004, 26:145-50. 10.1016\/j.jemermed.2003.05.005","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver L","year":"2014","unstructured":"Calver L, Isbister GK. High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings. Br J Clin Pharmacol. 2014, 77:880-6. 10.1111\/bcp.12272","journal-title":"Br J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128898-retrospective-review-of-the-efficacy-of-droperidol-compared-to-prochlorperazine-for-headache-management-in-the-emergency-department","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:09Z","timestamp":1707508809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128898-retrospective-review-of-the-efficacy-of-droperidol-compared-to-prochlorperazine-for-headache-management-in-the-emergency-department"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.39848","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}